tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

180 Life Sciences Enters $500M Sales Agreement

Story Highlights
  • 180 Life Sciences Corp. signed a Sales Agreement to sell up to $500 million in common stock.
  • A warrant holder exercised options to purchase shares, exempt from registration, on August 11, 2025.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
180 Life Sciences Enters $500M Sales Agreement

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

180 Life Sciences ( (ATNF) ) just unveiled an announcement.

On August 13, 2025, 180 Life Sciences Corp. entered into a Sales Agreement with Clear Street LLC to sell up to $500 million of its common stock. This agreement allows the company to sell shares through negotiated transactions or at-the-market offerings, with Clear Street acting as the sales agent. The company retains the right to designate the maximum amount of stock to be sold and can suspend or terminate the agreement with proper notice. Additionally, on August 11, 2025, a holder exercised warrants to purchase shares of the company’s common stock, which were exempt from registration under the Securities Act.

More about 180 Life Sciences

Average Trading Volume: 7,613,427

Technical Sentiment Signal: Buy

Current Market Cap: $1.58B

For an in-depth examination of ATNF stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1